Genomic and Transcriptome Profiling in Advanced Pancreatic Cancer
In a groundbreaking advance in the relentless battle against pancreatic cancer, a multinational research team has unveiled comprehensive insights from the COMPASS trial, revealing the intricate genomic landscape of advanced pancreatic tumors. Utilizing state-of-the-art whole genome and transcriptome sequencing technologies, this study offers an unprecedented molecular portrait that could revolutionize diagnostic approaches and therapeutic strategies […]

What's Your Reaction?






